- Home
- PNTG vs EYPT Comparison
PNTG vs EYPT Comparison
Compare PNTG & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNTG
- EYPT
- Stock Information
- Founded
- PNTG 2019
- EYPT 1987
- Country
- PNTG United States
- EYPT United States
- Employees
- PNTG N/A
- EYPT N/A
- Industry
- PNTG Medical/Nursing Services
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- PNTG Health Care
- EYPT Industrials
- Exchange
- PNTG Nasdaq
- EYPT Nasdaq
- Market Cap
- PNTG 833.6M
- EYPT 741.0M
- IPO Year
- PNTG N/A
- EYPT 2005
- Fundamental
- Price
- PNTG $25.03
- EYPT $13.11
- Analyst Decision
- PNTG Buy
- EYPT Strong Buy
- Analyst Count
- PNTG 6
- EYPT 6
- Target Price
- PNTG $35.00
- EYPT $25.83
- AVG Volume (30 Days)
- PNTG 274.9K
- EYPT 1.1M
- Earning Date
- PNTG 11-05-2025
- EYPT 11-06-2025
- Dividend Yield
- PNTG N/A
- EYPT N/A
- EPS Growth
- PNTG 20.56
- EYPT N/A
- EPS
- PNTG 0.77
- EYPT N/A
- Revenue
- PNTG $798,923,000.00
- EYPT $51,898,000.00
- Revenue This Year
- PNTG $28.29
- EYPT N/A
- Revenue Next Year
- PNTG $11.53
- EYPT N/A
- P/E Ratio
- PNTG $33.50
- EYPT N/A
- Revenue Growth
- PNTG 30.58
- EYPT 2.99
- 52 Week Low
- PNTG $21.18
- EYPT $3.91
- 52 Week High
- PNTG $36.20
- EYPT $14.91
- Technical
- Relative Strength Index (RSI)
- PNTG 51.65
- EYPT 51.20
- Support Level
- PNTG $24.71
- EYPT $12.54
- Resistance Level
- PNTG $26.42
- EYPT $14.04
- Average True Range (ATR)
- PNTG 0.77
- EYPT 0.86
- MACD
- PNTG 0.06
- EYPT -0.14
- Stochastic Oscillator
- PNTG 50.00
- EYPT 22.15
About PNTG The Pennant Group Inc.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.